New York City, NY -- (SBWIRE) -- 10/15/2013 -- StockMarketIntel.com issues a special report on the following stocks: Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY), Micron Technology, Inc. (NASDAQ:MU), Antares Pharma Inc (NASDAQ:ATRS), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)
Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) declined -0.09%, trading on 471,502 shares, to end the trade at $68.10. The stock changed hands in a range of $67.93 to $68.21, bringing its market capitalization to about $219.80 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $61.50 and was moved to the maximum level of $73.90. Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage. The Group manages its Food and Beverages business through three geographic zones (Zone Europe, Zone Americas and Zone Asia, Oceania and Africa) and globally for Nestle Waters, Nestle Nutrition and Other Food and Beverages (Others).
Why Should Investors Buy NSRGY After the Recent Fall? Just Go Here and Find Out
Micron Technology, Inc. (NASDAQ:MU) added 1.37%, to complete the trading session at $17.07, with a total volume of 62.90 million shares. The stock, on average, trades on a volume of 51.85 million shares. It floated in a range of $16.17 to $17.15 during the last trading session, with a beta value of 1.18. Its market capitalization now moved to about $17.66 billion. In the past 52 weeks, the share price has not declined below $5.16 and above $18.85. Micron Technology, Inc., is a global manufacturer and marketer of semiconductor devices, principally NAND Flash, DRAM and NOR Flash memory, as well as other memory technologies, packaging solutions and semiconductor systems for use in computing, consumer, networking, automotive, industrial, embedded and mobile products. In addition, the Company manufactures semiconductor components for CMOS images sensors and other semiconductor products.
For How Long MU will fight for Profitability? Read This Trend Analysis report
Antares Pharma Inc (NASDAQ:ATRS) added 3.53% and was in a range of $4.57-$5.15 before closing at $4.69. The stock completed the day with a total volume of 12.57 million shares, versus an average volume of 1.61 million shares. The share price hit its 52-week low of $3.35 and $5.15 was the best price. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company’s subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR), with Teva and Ferring being its two primary customers.
For How Long ATRS Gloss will Attract Investors? Find out via this report
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) added 7.52% yesterday, bringing its market capitalization around $276.40 million. The share price, after opening at $2.65, made a high of $2.87 and hovered above $2.60 to end the day at $2.86. The total number of shares that changed hands during the session was 8.56 million shares, as compared to average trading volume of 3.80 million shares. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
Will ACHN Continue To Move Higher? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)